Paromomycin sulfate is an effective treatment for balantidiasis in captive cynomolgus monkeys.


Journal

Experimental animals
ISSN: 1881-7122
Titre abrégé: Exp Anim
Pays: Japan
ID NLM: 9604830

Informations de publication

Date de publication:
14 Aug 2019
Historique:
pubmed: 1 3 2019
medline: 23 11 2019
entrez: 1 3 2019
Statut: ppublish

Résumé

There are few effective antimicrobial agents against Balantidium coli infection. The effect of paromomycin sulfate (PS) against B. coli was confirmed in this study of 596 captive cynomolgus monkeys. In several trials, the minimum dose and duration of oral administration of PS were 25 mg/day for 5 + 5 days, with a 2-day withdrawal interval. To facilitate daily PS administration, pumpkin cakes supplemented with PS were made, which not only resulted in precise effects but also increased the efficiency of preparation and administration of PS by the animal care staff. No cysts or trophozoites were detected at 14 or 16 days after the last treatments. There were no obvious differences in blood and biochemical parameters between before and after administration of PS. These results indicate that PS is effective for elimination of B. coli without hematological side effects. These data could contribute to the control of microbiological pathogens during veterinary care and colony management in primate facilities.

Identifiants

pubmed: 30814394
doi: 10.1538/expanim.18-0133
pmc: PMC6699974
doi:

Substances chimiques

Antiprotozoal Agents 0
Paromomycin 61JJC8N5ZK

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

285-292

Références

J Clin Microbiol. 2001 Mar;39(3):971-6
pubmed: 11230413
Clin Microbiol Rev. 2008 Oct;21(4):626-38
pubmed: 18854484
Trans R Soc Trop Med Hyg. 2009 Jul;103(7):653-60
pubmed: 18947845
Vet Parasitol. 2009 Jul 7;163(1-2):15-7
pubmed: 19428186
Nihon Juigaku Zasshi. 1990 Dec;52(6):1323-4
pubmed: 2287142
J Clin Microbiol. 1979 Dec;10(6):852-3
pubmed: 574877
J Am Vet Med Assoc. 1982 Dec 1;181(11):1345-7
pubmed: 7174457
Antimicrob Agents Chemother. 1994 Feb;38(2):170-3
pubmed: 8192437
Zentralbl Veterinarmed B. 1997 Oct;44(8):501-12
pubmed: 9394615

Auteurs

Shinichiro Nakamura (S)

Research Center for Animal Life Science, Shiga University of Medical Science, Seta Tsukinowa-cho, Otsu, Shiga 520-2192, Japan.

Iori Itagaki (I)

Research Center for Animal Life Science, Shiga University of Medical Science, Seta Tsukinowa-cho, Otsu, Shiga 520-2192, Japan.
The Corporation for Production and Research of Laboratory Primates, 1-16-2 Sakura, Tsukuba, Ibaraki 305-0003, Japan.

Takahiro Nakagawa (T)

Research Center for Animal Life Science, Shiga University of Medical Science, Seta Tsukinowa-cho, Otsu, Shiga 520-2192, Japan.

Ikuo Kawamoto (I)

Research Center for Animal Life Science, Shiga University of Medical Science, Seta Tsukinowa-cho, Otsu, Shiga 520-2192, Japan.

Takahiro Asano (T)

Research Center for Animal Life Science, Shiga University of Medical Science, Seta Tsukinowa-cho, Otsu, Shiga 520-2192, Japan.
KAC Co. Ltd., 40 Nishinokyo-Nishigekko-cho, Nakagyo-ku, Kyoto, Kyoto 604-8423, Japan.

Daichi Arakawa (D)

Research Center for Animal Life Science, Shiga University of Medical Science, Seta Tsukinowa-cho, Otsu, Shiga 520-2192, Japan.
KAC Co. Ltd., 40 Nishinokyo-Nishigekko-cho, Nakagyo-ku, Kyoto, Kyoto 604-8423, Japan.

Hideaki Tsuchiya (H)

Research Center for Animal Life Science, Shiga University of Medical Science, Seta Tsukinowa-cho, Otsu, Shiga 520-2192, Japan.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH